Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 15:20 save search
Lottery.com Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting
Published: 2023-08-08 (Crawled : 15:20) - globenewswire.com
LTRY | $1.99 -0.51% 5.8K
|
|
| O: -3.01%
H: 0.0%
C: -5.17%
lottery.com meeting
Check Point Software Technologies Ltd. Shareholders Approve All 2023 Annual General Meeting Proposals
Published: 2023-08-03 (Crawled : 15:20) - globenewswire.com
CHKP | News | $157.9 -0.3% -0.3% 670K
|
Technology Services
|
| O: -0.18%
H: 0.0%
C: 0.0%
software meeting
Michigan Public Service Commission approves DTE’s landmark clean energy plan
Published: 2023-07-26 (Crawled : 15:20) - globenewswire.com
DTE | $108.57 1.96% 0.0% 980K
|
Utilities
|
| O: 0.05%
H: 1.03%
C: 0.32%
energy service
Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors
Published: 2023-05-25 (Crawled : 15:20) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
| Email alert
Add to watchlist
meeting
Inter&Co Announces that FINRA Approved Inter&CO Securities LLC to Operate as a US Broker During Nasdaq’s Opening Bell Ceremony
Published: 2023-05-12 (Crawled : 15:20) - globenewswire.com
INTR | $5.22 2.35% 2.3% 540K
|
n/a
|
| O: 0.0%
H: 4.17%
C: -1.67%
approved
Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approval
Published: 2023-04-18 (Crawled : 15:20) - biospace.com/
NBIO | $0.0924 15.32% 450
|
|
| O: -7.99%
H: 8.68%
C: 3.77%
fda approval review research phase 2
Mirum Submits for European Approval of LIVMARLI in Progressive Familial Intrahepatic Cholestasis
Published: 2023-04-05 (Crawled : 15:20) - biospace.com/
MIRM | News | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.2%
H: 1.97%
C: -0.76%
approval livmarli
Skye Bioscience Receives Human Research Ethics Committee Approval to Start Multiple Ascending Dose Arm of Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-03-15 (Crawled : 15:20) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K
|
Transportation and Warehousing
|
| O: -3.85%
H: 8.0%
C: 1.2%
sbi-100 arm approval bioscience research study phase 1
HII Receives Additive Manufacturing Approval from Naval Sea Systems Command
Published: 2023-03-07 (Crawled : 15:20) - globenewswire.com
HII | $271.66 1.05% 0.0% 350K
|
Electronic Technology
|
| O: 0.26%
H: 0.31%
C: -1.56%
approval
SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury
Published: 2023-02-09 (Crawled : 15:20) - biospace.com/
ICU A | $0.41 -24.07% -31.71% 7.4M
|
|
| O: 12.29%
H: 9.65%
C: -24.49%
fda device medical kidney approval study
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Published: 2023-01-26 (Crawled : 15:20) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.23%
H: 0.33%
C: -0.16%
fda living diabetic
NYCRC ANNOUNCES I-829 PETITION APPROVALS IN ITS SUBWAY WI-FI INFRASTRUCTURE EB-5 OFFERING
Published: 2023-01-04 (Crawled : 15:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 5.72%
H: 0.0%
C: 0.0%
offering
SOUTHWEST AIRLINES CUSTOMER SERVICE EMPLOYEES APPROVE NEW FIVE-YEAR CONTRACT
Published: 2022-12-16 (Crawled : 15:20) - prnewswire.com
LUV | $29.38 1.1% -0.1% 6.9M
|
Transportation
|
| O: -0.72%
H: 1.57%
C: 0.7%
airlines service contract
Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma Approved in China
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
YMAB | $15.15 1.0% 0.99% 470K
|
Health Technology
|
| O: 0.22%
H: 3.45%
C: -0.86%
danyelza treatment approved china
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
VBIV | $0.6396 1.57% 1.55% 160K
|
Health Technology
|
| O: 0.79%
H: 12.25%
C: 2.24%
hepatitis canada health approval vaccine
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping CatheterThe flagship 3D mapping catheter from Acutus Medical has been certified under the new European Medical Device Regulations
Published: 2022-12-06 (Crawled : 15:20) - biospace.com/
AFIB | $0.167 -4.3% -4.49% 400K
|
Health Technology
|
| O: 1.8%
H: 6.0%
C: -9.08%
device medical imaging
HEXO Corp.’s Shareholders Approve Note Transaction with Tilray Brands
Published: 2022-07-05 (Crawled : 15:20) - globenewswire.com
HEXO | $0.71 -0.14% 310K
|
Process Industries
|
| O: 0.0%
H: 1.47%
C: -1.66%
brands tilray
Middlefield Banc Corp. Receives Shareholder Approval for Merger with Liberty Bancshares, Inc.
Published: 2022-11-08 (Crawled : 15:20) - globenewswire.com
MBCN | $22.175 0.16% 0.16% 11K
|
Finance
|
| O: 0.17%
H: 0.86%
C: -0.31%
liberty approval
Sanofi and AstraZeneca Win EU Approval for First Preventative RSV Antibody in...
Published: 2022-11-04 (Crawled : 15:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
antibody approval sanofi
New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 9.68%
H: 45.69%
C: 26.56%
stendra
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.